You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3201 to 3225 of about 5861
Next 25
05/25/2009
Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
Brain Tumor Talk Radio
05/24/2009
IBTA E-News May 24 2009
05/22/2009
Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors.
05/14/2009
Very late relapses in glioblastoma long-term survivors.
ASCO Abstracts now available online!
A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501).
Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity.
Epidermal growth factor receptor variant III (EGFRvIII) vaccine (CDX-110) in GBM.
Targeting brain tumor stem cells using a bispecific antibody directed against CD133+ and EGFRvIII+.
A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma.
A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.
A phase I evaluation of intravenous TM601 in recurrent glioblastoma: Use of perfusion MRI to monitor antiangiogenic effects.
The Role of Supplements (including Anti-Oxidants) in Cancer Treatment
05/11/2009
Brain Tumour UK`s 9th Annual Patient and Carer Conference 7-8 July 2009
05/07/2009
Grey Ribbon Crusade ™ Promotes National Unification in the Fight Against Brain Tumors
Diagnosis Brain Tumor: You Are NOT Alone III A conference for families dealing with brain tumors - This weekend in NJ!
National Brain Tumor Society - Regional Conference in Houston, TX with M.D. Anderson Cancer Center, May 15-17!
Free Neurological Seminar - May 9th, Long Island, NY
The survival impact of postoperative infection in patients with glioblastoma multiforme.
Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.
The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
Hats recognize National Brain Tumor Awareness Month